Riskpilot← Back to searchSign inGet full accessVITALO AS
ASActiveOrg 913298608Badeveien 6, 1444 DrøbakMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
NOK 8,4M
-3% vs 2023
EBITDA margin
50.7%
-8% vs 2023
Equity ratio
82.4%
Financial strength
Net profit 2024
NOK 3,4M
+2% vs 2023
| Revenue | NOK 8,4M | -3% |
| EBITDA | NOK 4,3M | -8% |
| Net profit | NOK 3,4M | +2% |
| Total assets | NOK 9,8M | +54% |
| Equity | NOK 8,1M | +72% |
| Employees | 1 | — |
Legal name
VITALO AS
Org number
913298608
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
27. februar 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Legevirksomhet med spesialisering innenfor øre, nese, hals. Kjøp og salg av medisinsk utstyr. Omsetning og utleie av fast eiendom, aksjehandel og investeringer i andre selskaper.
Address
Badeveien 6, 1444 Drøbak
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 629 | 7 644 | 7 754 | 8 628 | 8 388 |
| Staff expenses | −1 020 | −1 251 | −1 369 | −1 054 | −1 051 |
| EBITDA | 4 376 | 3 849 | 4 101 | 4 607 | 4 253 |
| Depreciation & amort. | −223 | −223 | −5 | −17 | −17 |
| EBIT | 4 152 | 3 626 | 4 096 | 4 589 | 4 236 |
| Net financials | 1 813 | −2 311 | −1 287 | −243 | 123 |
| Profit before tax | 5 966 | 1 315 | 2 808 | 4 347 | 4 359 |
| Tax | 917 | 799 | 905 | 1 020 | 969 |
| Net profit | 5 048 | 516 | 1 903 | 3 327 | 3 390 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 485 | 7 408 | 5 881 | 6 389 | 9 813 |
| Equity | 5 600 | 566 | 2 469 | 4 696 | 8 086 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 886 | 6 842 | 3 412 | 1 692 | 1 727 |
| Total debt | 3 886 | 6 842 | 3 412 | 1 692 | 1 727 |
EBITDA margin
50.7%
This company
15.8%
Market median
+221% vs market
20202024
Equity ratio
82.4%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
41.9%
This company
18.4%
Market median
+128% vs market
20202024
Net profit margin
40.4%
This company
8.1%
Market median
+399% vs market
20202024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Chief Executive Officer | Chief Executive Officer | 2014 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VITALO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kalle-Kustaa Hemiö | Chief Executive Officer | 0 companies |